Meeting Banner
Abstract #3398

Can longitudinal diffusion-weighted imaging of the basal ganglia be used as a surrogate marker in preclinical Huntington’s disease?

Chris Patrick Pflanz1, Marina Charquero-Ballester2, Adnan Majid3, Anderson Winkler1, Emmanuel Vallee1, Mark Jenkinson1, Adam Aron3, and Gwenaelle Douaud1

1FMRIB Centre, University of Oxford, Oxford, United Kingdom, 2Oxford, United Kingdom, 3San Diego, CA, United States

Huntington’s disease is a monogenetic, neurodegenerative movement disorder that is amenable to predictive genetic testing. Here, we investigated whether longitudinal diffusion-weighted imaging of the basal ganglia could be used to detect early microstructural changes in participants with presymptomatic Huntington’s disease (preHD). We found the first results showing significant longitudinal changes in the microstructure of the basal ganglia within a preclinical HD population. We further showed that, while FA and MD might be less sensitive to longitudinal changes than volumetric measures, they provide mechanistic insights into the underlying physiopathological process that are complementary to the monotonic, non-specific changes in the volume of the basal ganglia.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.

Keywords